GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Tanke Biosciences TNBI · USD

N/A · US listing · 🇺🇸 United States

Compare

0.03

0.00%

Close of 5 Nov 2026, in USD

Tanke Biosciences annual report

Filed with the US Securities and Exchange Commission

10-K

The latest annual report covers the year to 31 Dec 2012, filed on 15 Apr 2013.

Read the 10-K on SEC.gov ↗

Five-year highlights

In USD.

FY2025FY2024FY2023FY2022FY2021
Revenue$8,430————
Operating income−$257,865−$117,421−$94,160−$128,179−$668,030
Net income−$274,464−$119,931−$82,521−$98,150−$722,984
Free cash flow−$36,990−$34,900−$74,664−$59,180−$3,530
Total assets$74,471$65,522$69,156$7,318$41,495
Shareholders' equity−$398,806−$183,341−$95,655−$88,134−$59,984

Filings

Newest first, from SEC EDGAR

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.